1 / 9

Drug Target Structure

Drug Target Structure. Physical methods of structure determination. Drug Targets (1). Biomolecular Drug Target Receptor Enzyme Transcription Factor Antigen Gene sequence. Drug Type agonist / antagonist enzyme inhibitor covalent / non-covalent Antibody

mimi
Télécharger la présentation

Drug Target Structure

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Drug Target Structure • Physical methods of structure determination l2PHA406 - Drug Design

  2. Drug Targets (1) • Biomolecular Drug Target • Receptor • Enzyme • Transcription Factor • Antigen • Gene sequence • Drug Type • agonist / antagonist • enzyme inhibitor • covalent / non-covalent • Antibody • anti-sense oligonucleotide l2PHA406 - Drug Design

  3. Biomolecular Drug Target • Receptor, Enzyme, Transcription Factor, Antigen, • Gene sequence • Techniques for drug target structure determination • Atomic resolution x-ray diffraction ( 1.5-3.0Å) • Neutron diffraction (~ 1.5-3.0Å) • NMR (1H,15N, 31P and 13C) (~ 5.0Å) • Atomic Force Microscopy (AFM) (~ 10-100Å) • Electron microscopy (often cryogenic) ( ~ 5.0Å) Target physical attributes - methodology, resolution (2) l2PHA406 - Drug Design

  4. X-ray co-ordinates for the complex between the enzyme HIV-1 protease and Amprenavir Structural method - X-ray diffraction (3) l2PHA406 - Drug Design

  5. NMR ensemble of BLK SH2 domain (a tyrosine kinase anti-cancer target comprising 20 structures, distance geometry solutions of NOE, nuclear overhauser enhancement experiments) Structural method - Nuclear Magnetic Resonance (4) l2PHA406 - Drug Design

  6. Structural method - Atomic Force Microscopy (5) A membrane protein from E.coli (a porin controlling osmotic environment) (a) High resolution topograph of the perisplasmic surface of 2-D OmpF porin crystals. The average shown was calculated from 25 translationally aligned subframes. To allow comparison, the electron density based on the X-ray structure of the OmpF trimer was rendered at a lateral resolution of 15Å. Zebra-like contours (dark and light blue) on the overlaid transparent AFM topograph mark zones of identical altitude, with a height difference between contours of 1Å. (b) Atomic model of protein-protein and lipid-protein interactions based on the X-ray structure of the porin trimer (from http://www.mih.unibas.ch/Booklet/Booklet96/Chapter3/Chapter3.html) l2PHA406 - Drug Design

  7. Structural method - Cryo-electron microscopy (6) A bacterial ‘molecular chaperone’ complex (GroEL-GroES) which is ATP dependent changes it state. The apical chains interact with other proteins undergoing protein folding duration ‘maturation’ on being released from their synthetic apparatus. l2PHA406 - Drug Design

  8. Structural method - Cryo-electron microscopy (7) 9Å resolution of the nicotinic acetylcholine receptor in a pore open (white) and pore closed state (blue). Ionic conduction occurs when the pore is open. l2PHA406 - Drug Design

  9. Fatty Acid Synthetase - bacterial Structural method - Cryo-electron microscopy (8) l2PHA406 - Drug Design

More Related